ClassID:

95253

C07D403/14 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings

Recent Application in this class:
#301
20250066389
2025-02-27

HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME

#302
20250066328
2025-02-27

PARP7 INHIBITORS

#303
20250064787
2025-02-27

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

#304
20250063944
2025-02-20

COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS

#305
20250059196
2025-02-20

TRICYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#306
20250059171
2025-02-20

ANTIVIRAL COMPOUNDS

#307
20250059170
2025-02-20

SOLID STATE FORMS OF AN FGFR INHIBITOR

#308
20250051313
2025-02-13

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

#309
20250051312
2025-02-13

Process for Manufacturing Pibrentasvir Active Drug Substance

#310
20250051290
2025-02-13

NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF

#311
20250051286
2025-02-13

SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF

#312
20250051273
2025-02-13

Glucose and Lipid Metabolism Regulating Agents, Pharmaceutical Compositions Comprising the Same, and Treatment Methods

#313
20250049033
2025-02-13

PESTICIDALLY ACTIVE PYRIDAZINONE COMPOUNDS

#314
20250048920
2025-02-06

COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF

#315
20250042879
2025-02-06

HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME

#316
20250034122
2025-01-30

SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS

#317
20250034120
2025-01-30

PYRIDAZINONES AS PARP7 INHIBITORS

#318
20250034119
2025-01-30

COMPOUNDS, COMPOSITIONS, AND METHODS

#319
20250034116
2025-01-30

1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF

#320
20250032454
2025-01-30

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

#321
20250026763
2025-01-23

EGFR INHIBITORS AND METHODS OF USE THEREOF

#322
20250026759
2025-01-23

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

#323
20250026747
2025-01-23

COLIBACTIN DERIVATIVES AND METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING CANCER

#324
20250019369
2025-01-16

N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 inhibitors

#325
20250011339
2025-01-09

STING AGONIST COMPOUNDS AND METHODS OF USE

#326
20250011333
2025-01-09

PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

#327
20250011305
2025-01-09

THERAPEUTIC COCRYSTALS OF 3-{[5-(AZETIDINE-1-YLCARBONYL)PYRAZIN-2-YL]OXY}-5-{[(1S)-1-METHYL-2-(METHOXY)ETHYL]OXY)-N-(5-METHYLPYRAZIN-2-YL)BENZAMIDE

#328
20250009742
2025-01-09

NOVEL CAPSID ASSEMBLY INHIBITORS

#329
20250002489
2025-01-02

BIFUNCTIONAL COMPOUNDS FOR DEGRADING ITK VIA UBIQUITIN PROTEOSOME PATHWAY

#330
20250002479
2025-01-02

Pyrazolopyridine derivatives and uses thereof

#331
20240425496
2024-12-26

AZETIDINYL PYRIMIDINES AND USES THEREOF

#332
20240425493
2024-12-26

SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS

#333
20240425480
2024-12-26

NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

#334
20240417392
2024-12-19

3,3-DIFLUOROALLYLAMINES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#335
20240417391
2024-12-19

HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES

#336
20240417388
2024-12-19

BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6

#337
20240417386
2024-12-19

INHIBITORS OF RET

#338
20240409555
2024-12-12

CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF

#339
20240409535
2024-12-12

SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE

#340
20240409530
2024-12-12

Disubstituted Pyrimidine Compounds for Ketohexokinase Inhibition

#341
20240409509
2024-12-12

COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

#342
20240408088
2024-12-12

PYRAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE

#343
20240400542
2024-12-05

SULFONYL-TRIAZOLES USEFUL AS COVALENT KINASE LIGANDS

#344
20240400541
2024-12-05

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#345
20240393330
2024-11-28

4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF

#346
20240391905
2024-11-28

BIPYRROLINONE COMPOUND

#347
20240383923
2024-11-21

HETEROARYL DERIVATIVE AND USE THEREOF

#348
20240382612
2024-11-21

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

#349
20240382481
2024-11-21

SRPK INHIBITORS

#350
20240376129
2024-11-14

METALLODRUG THERAPEUTIC COMPOUNDS AND PRODRUGS OF METALLODRUG THERAPEUTIC COMPOUNDS

#351
20240376117
2024-11-14

IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE

#352
20240376114
2024-11-14

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

#353
20240376096
2024-11-14

SMALL MOLECULE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) AND IKZF2 (HELIOS) DEGRADERS AND METHODS OF USE THEREOF

#354
20240376086
2024-11-14

SOLID FORM OF RHO-ASSOCIATED PROTEIN KINASE INHIBITOR OR SOLVATE THEREOF, PREPARATION METHOD AND USE THEREOF

#355
20240376079
2024-11-14

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof

#356
20240376073
2024-11-14

QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#357
20240374606
2024-11-14

SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER

#358
20240374598
2024-11-14

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#359
20240374582
2024-11-14

SELECTIVE INHIBITORS OF ROCK1 AND ROCK2 PROTEIN KINASES AND THEIR USES THEREOF

#360
20240368184
2024-11-07

PIKfyve Inhibitors

#361
20240368181
2024-11-07

QUINOXALINE DERIVATIVES AND USES THEREOF

#362
20240368163
2024-11-07

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#363
20240368136
2024-11-07

BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS

#364
20240368133
2024-11-07

Compounds for the Treatment of Pain, in Particular, Neuropathic Pain, and/or Other Diseases or Disorders that are Associated with AT2R and/or AT2R Mediated Signaling

#365
20240368132
2024-11-07

ROCK2 INHIBITORS AND USES THEREOF

#366
20240368119
2024-11-07

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

#367
20240368117
2024-11-07

HETEROCYCLIC COMPOUNDS

#368
20240368091
2024-11-07

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

#369
20240368078
2024-11-07

ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

#370
20240366614
2024-11-07

ARYLQUINAZOLINES

#371
20240365659
2024-10-31

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#372
20240360121
2024-10-31

GLS1 INHIBITORS FOR TREATING DISEASE

#373
20240360106
2024-10-31

THYROID HORMONE RECEPTOR AGONISTS AND USES THEREOF

#374
20240360105
2024-10-31

PROCESS FOR POLYAMIDE SYNTHESIS

#375
20240360104
2024-10-31

TRANSCRIPTIONAL ENHANCED ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF

#376
20240360103
2024-10-31

COMPLEMENT INHIBITION

#377
20240360084
2024-10-31

PYRAZOLE AND IMIDAZOLE COMPOUNDS FOR INHIBITION OF IL-17 AND RORGAMMA

#378
20240352046
2024-10-24

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF

#379
20240352025
2024-10-24

1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES

#380
20240352005
2024-10-24

Prodigiosin Analogs And Methods Of Use

#381
20240351988
2024-10-24

ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS

#382
20240351984
2024-10-24

INDOLINE COMPOUNDS FOR INHIBITING KIF18A

#383
20240343727
2024-10-17

PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

#384
20240336611
2024-10-10

ANALOGS FOR THE TREATMENT OF DISEASE

#385
20240336601
2024-10-10

4-PHENYL-INDOLE DERIVATIVES AND RELATED USES

#386
20240336599
2024-10-10

PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS

#387
20240336598
2024-10-10

Hydroquinazoline derivatives for the treatment of a disease or disorder

#388
20240336574
2024-10-10

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#389
20240335427
2024-10-10

SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)

#390
20240334822
2024-10-03

COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

#391
20240327402
2024-10-03

PYRIMIDINE OR PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PHARMACY

#392
20240327387
2024-10-03

TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS

#393
20240327386
2024-10-03

AHR INHIBITOR, USE THEREOF, AND PREPARATION METHOD THEREFOR

#394
20240327375
2024-10-03

SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR

#395
20240327356
2024-10-03

PYRIMIDINE BASED RAS MODULATORS AND USES THEREOF

#396
20240327351
2024-10-03

AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#397
20240324456
2024-09-26

HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES

#398
20240324453
2024-09-26

LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND

#399
20240324446
2024-09-26

ELECTROLUMINESCENT DEVICES

#400
20240317757
2024-09-26

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

#401
20240317738
2024-09-26

SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE

#402
20240317721
2024-09-26

PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN

#403
20240317720
2024-09-26

COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

#404
20240317719
2024-09-26

Compounds useful for treating gastrointestinal tract disorders

#405
20240317705
2024-09-26

POTASSIUM CHANNEL MODULATORS

#406
20240308988
2024-09-19

Method For Controlling Diamide Resistant Pests and Compounds Therefor

#407
20240308987
2024-09-19

SMALL MOLECULE INHIBITOR AGAINST NASOPHARYNGEAL CARCINOMA, PREPARATION METHOD AND APPLICATION THEREOF

#408
20240300970
2024-09-12

LIGHT-EMITTING DEVICE AND DISPLAY DEVICE

#409
20240300936
2024-09-12

PREPARATION OF SUBSTITUTED 1,2-DIAMINOHETEROCYCLIC COMPOUND DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS

#410
20240300925
2024-09-12

TETRAHYDROPYRROLOCYCLIC COMPOUND AND APPLICATION THEREOF

#411
20240300905
2024-09-12

Quinazoline Compounds and Uses

#412
20240299386
2024-09-12

Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof

#413
20240299360
2024-09-12

ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF

#414
20240294524
2024-09-05

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#415
20240294509
2024-09-05

PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR

#416
20240294508
2024-09-05

RIP1 MODULATORS INCLUDING AZETIDINE CYCLIC UREAS, PREPARATIONS, AND USES THEREOF

#417
20240294503
2024-09-05

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#418
20240287047
2024-08-29

PESTICIDALLY ACTIVE DIAZINE-AMIDE COMPOUNDS

#419
20240285621
2024-08-29

PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS

#420
20240279206
2024-08-22

Modulators of RAS GTPase

#421
20240279205
2024-08-22

NOVEL BENZIMIDAZOLE DERIVATIVE

#422
20240276875
2024-08-15

COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

#423
20240270723
2024-08-15

SUBSTITUTED HETEROCYCLIC COMPOUNDS

#424
20240270722
2024-08-15

POLO LIKE KINASE 4 INHIBITORS

#425
20240270721
2024-08-15

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

#426
20240270720
2024-08-15

INDAZOLE YL BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

#427
20240270699
2024-08-15

COMPOUNDS HAVING N-ARYLPYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC AGENTS

#428
20240270697
2024-08-15

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#429
20240268222
2024-08-08

MATERIALS FOR ORGANIC LIGHT EMITTING DEVICES

#430
20240262811
2024-08-08

BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

#431
20240261416
2024-08-08

SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#432
20240260290
2024-08-01

COMPOSITION, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS INCLUDING THE SAME

#433
20240254129
2024-08-01

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#434
20240252488
2024-08-01

MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF

#435
20240251666
2024-07-25

HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND COMPOSITION FOR ORGANIC MATERIAL LAYER COMPRISING THE SAME

#436
20240246955
2024-07-25

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

#437
20240246948
2024-07-25

BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT

#438
20240246940
2024-07-25

HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF

#439
20240246938
2024-07-25

Nitrogen-containing compound, and organic electroluminescent device and electronic apparatus thereof

#440
20240246920
2024-07-25

TRIAZOLE DERIVATIVES WITH ANTIFUNGAL ACTIVITY

#441
20240246909
2024-07-25

EBNA1 Inhibitors and Methods Using Same

#442
20240245684
2024-07-25

NITRIC OXIDE RELEASING PHOSPHODIESTERASE TYPE 5 INHIBITOR

#443
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#444
20240239784
2024-07-18

INDOLE COMPOUNDS AND METHODS OF USE

#445
20240239781
2024-07-18

1H-PYRAZOLE DERIVATIVES AS SIGMA LIGANDS

#446
20240239774
2024-07-18

SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF

#447
20240239757
2024-07-18

PHTHALAZINONE DERIVATES AS NLRP3 INFLAMMASOME INHIBITORS

#448
20240239754
2024-07-18

Phenanthroimidazole derivative, and preparation method therefor and application thereof

#449
20240238281
2024-07-18

PIPERAZINE DERIVATIVES AND APPLICATION THEREOF

#450
20240228503
2024-07-11

Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors

#451
20240228469
2024-07-11

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

#452
20240228467
2024-07-11

INDIRUBIN COMPOUNDS AND METHODS THEREOF

#453
20240226106
2024-07-11

INHIBITORS OF PLASMA KALLIKREIN

#454
20240217989
2024-07-04

Heteroaryl Fluoroalkenes As DGK Inhibitors

#455
20240217968
2024-07-04

PHARMACEUTICAL COMPOUND

#456
20240217967
2024-07-04

INDOLINE DERIVATIVES AS DDRS INHIBITORS

#457
20240217963
2024-07-04

RECEPTOR-INTERACTING PROTEIN 1 INHIBITORS, PREPARATIONS, AND USES THEREOF

#458
20240217955
2024-07-04

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

#459
20240216386
2024-07-04

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

#460
20240215439
2024-06-27

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#461
20240208967
2024-06-27

Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof

#462
20240208965
2024-06-27

HETEROARYL ALKYLENE SUBSTITUTED 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

#463
20240208957
2024-06-27

TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K

#464
20240208948
2024-06-27

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#465
20240208947
2024-06-27

JAK1 SELECTIVE INHIBITORS

#466
20240208912
2024-06-27

MTA-Cooperative PRMT5 Inhibitors

#467
20240206207
2024-06-20

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE

#468
20240201177
2024-06-20

FLUORESCENT COMPOUND FOR IMMUNOHISCHEMISTRY AND DIAGNOSIS COMPOSITION FOR DETECTING BIOLOGICAL MATERIAL COMPRISING THE SAME

#469
20240199654
2024-06-20

CTLA-4 SMALL MOLECULE DEGRADATION AGENT AND APPLICATION THEREOF

#470
20240199641
2024-06-20

QUINAZOLINE-4(3H)-ONE DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#471
20240199640
2024-06-20

NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#472
20240199609
2024-06-20

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

#473
20240199607
2024-06-20

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

#474
20240199597
2024-06-20

SMALL MOLECULES FOR THE TREATMENT OF KINASE-RELATED DISEASES

#475
20240199588
2024-06-20

Chiral TACN/NOTA compounds/derivatives with and without metals for application

#476
20240199587
2024-06-20

HETEROCYCLIC COMPOUNDS

#477
20240199586
2024-06-20

COMPOUND OR TAUTOMER THEREOF, COMPOSITION, LAMINATE, OPTICAL FILM, IMAGE FORMING MATERIAL, AND METHOD FOR PRODUCING COMPOUND OR TAUTOMER THEREOF

#478
20240199584
2024-06-20

KRAS INHIBITORS

#479
20240199583
2024-06-20

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

#480
20240199554
2024-06-20

Inhibitors of receptor interacting protein kinase I for the treatment of disease

#481
20240199546
2024-06-20

INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF

#482
20240190849
2024-06-13

AMINOPYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE

#483
20240190848
2024-06-13

INHIBITORS OF LRRK2 KINASE

#484
20240190847
2024-06-13

INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS

#485
20240190844
2024-06-13

PYRIDAZINONES AS PARP7 INHIBITORS

#486
20240190840
2024-06-13

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#487
20240189322
2024-06-13

Tropomyosin-related kinase (trk) inhibitors

#488
20240188430
2024-06-06

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#489
20240182454
2024-06-06

Polycyclic Compound for Inhibiting RNA Helicase DHX33, and Application of Compound

#490
20240182448
2024-06-06

Triazine derivatives and methods of use thereof

#491
20240182446
2024-06-06

TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING

#492
20240174679
2024-05-30

HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#493
20240174665
2024-05-30

CDK2 INHIBITORS AND USES THEREOF

#494
20240174648
2024-05-30

Small Molecule Compound

#495
20240174645
2024-05-30

COMPOUND, PRODUCTION METHOD THEREFOR, COMPLEX, AND SHORT WAVELENGTH INFRARED FLUORESCENT AGENT

#496
20240172556
2024-05-23

ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF

#497
20240166663
2024-05-23

NOVEL PYRIMIDINE DERIVATIVE SHOWING INHIBITION EFFECT ON GROWTH OF CANCER CELLS

#498
20240166634
2024-05-23

Multi-aziridine compound

#499
20240166633
2024-05-23

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#500
20240166632
2024-05-23

PYRAZOLE COMPOUNDS SUBSTITUTED WITH HETEROARYL AND PHARMACEUTICAL USE THEREOF

#501
20240166601
2024-05-23

NLRX1 LIGANDS

#502
20240164210
2024-05-16

LIGHT EMITTING ELEMENT AND NITROGEN CONTAINING COMPOUND FOR THE SAME

#503
20240164208
2024-05-16

ORGANIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME

#504
20240158374
2024-05-16

Pyrazolopyridine derivatives and uses thereof

#505
20240158372
2024-05-16

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

#506
20240150365
2024-05-09

PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY

#507
20240150328
2024-05-09

METHODS AND COMPOUNDS FOR TREATING DISORDERS

#508
20240150327
2024-05-09

Bipyrazole derivatives as JAK inhibitors

#509
20240150326
2024-05-09

CARBOXAMIDE COMPOUNDS AND USES THEREOF

#510
20240150325
2024-05-09

NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS

#511
20240150321
2024-05-09

PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY

#512
20240150320
2024-05-09

Quaternary indazole glucocorticoid receptor antagonists

#513
20240147852
2024-05-02

Light-emitting element, light-emitting device, electronic device, lighting device, and organic compound

#514
20240140935
2024-05-02

NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT

#515
20240140932
2024-05-02

Cycloalkyl pyrimidines as ferroportin inhibitors

#516
20240132483
2024-04-25

GLP-1 Receptor Agonists and Uses Thereof

#517
20240132481
2024-04-25

COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME

#518
20240132477
2024-04-25

Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease

#519
20240130231
2024-04-18

MATERIALS FOR ELECTRONIC DEVICES

#520
20240124463
2024-04-18

PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS

#521
20240124448
2024-04-18

TYK2 inhibitors and compositions and methods thereof

#522
20240124428
2024-04-18

HETEROCYCLIC INHIBITORS OF PCSK9

#523
20240124426
2024-04-18

Polo like kinase 4 inhibitors

#524
20240124417
2024-04-18

COMPOUNDS USEFUL AS IMMUNOMODULATORS

#525
20240123079
2024-04-18

IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES

#526
20240116921
2024-04-11

LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2

#527
20240116902
2024-04-11

ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

#528
20240116901
2024-04-11

Substituted pyridine derivatives as SARM1 inhibitors

#529
20240116900
2024-04-11

NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND

#530
20240116899
2024-04-11

Beta-lactam derivatives for the treatment of diseases

#531
20240116894
2024-04-11

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

#532
20240109889
2024-04-04

DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT

#533
20240109871
2024-04-04

Anti-viral compounds

#534
20240109849
2024-04-04

DEBRIDING DRESSING FOR USE WITH NEGATIVE PRESSURE AND FLUID INSTILLATION

#535
20240107880
2024-03-28

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#536
20240107878
2024-03-28

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC MATERIAL LAYER

#537
20240101537
2024-03-28

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#538
20240101536
2024-03-28

Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity

#539
20240101532
2024-03-28

Heteroaryl carboxamide compound

#540
20240092773
2024-03-21

DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES

#541
20240092765
2024-03-21

Methods of inhibiting kinases

#542
20240092764
2024-03-21

KINASE INHIBITORS

#543
20240092763
2024-03-21

ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF

#544
20240092758
2024-03-21

IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

#545
20240091200
2024-03-21

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

#546
20240090327
2024-03-14

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

#547
20240083884
2024-03-14

COMPOUNDS AND METHOD FOR PREPARING THE SAME

#548
20240083883
2024-03-14

RAD51 BINDING INHIBITORS AND METHODS OF USE THEREOF

#549
20240083881
2024-03-14

Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof

#550
20240083880
2024-03-14

Near-infrared cyanine dyes and conjugates thereof

#551
20240083879
2024-03-14

OXALAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#552
20240077475
2024-03-07

PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING

#553
20240076291
2024-03-07

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#554
20240076286
2024-03-07

HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

#555
20240074309
2024-02-29

Organic electroluminescence device and compound for organic electroluminescence device

#556
20240067633
2024-02-29

KETOHEXOKINASE INHIBITOR AND USE THEREOF

#557
20240067631
2024-02-29

PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS

#558
20240065098
2024-02-22

Compounds

#559
20240065097
2024-02-22

Materials for organic light emitting devices

#560
20240059693
2024-02-22

FUSED BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES

#561
20240059655
2024-02-22

HETEROCYCLIC G-PROTEIN-COUPLED RECEPTOR 52 (GPR52) AGONISTS

#562
20240051970
2024-02-15

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#563
20240051946
2024-02-15

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

#564
20240051945
2024-02-15

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

#565
20240051940
2024-02-15

SULFONAMIDES WITH EGFR INHIBITION ACTIVITIES AND THEIR USE THEREOF

#566
20240043403
2024-02-08

HETEROARYL CARBOXAMIDE COMPOUND

#567
20240034728
2024-02-01

PYRIDAZINONES AS PARP7 INHIBITORS

#568
20240034726
2024-02-01

MAP KINASE KINASE (MKK7) INHIBITORS AND USES THEREOF

#569
20240025885
2024-01-25

TRIAZINE DERIVATIVES AND METHODS OF USE THEREOF

#570
20240025884
2024-01-25

Compounds as GCNinhibitors, pharmaceutical compositions and uses thereof

#571
20240025882
2024-01-25

Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

#572
20240025880
2024-01-25

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#573
20240025863
2024-01-25

SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

#574
20240023434
2024-01-18

ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

#575
20240023433
2024-01-18

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, MANUFACTURING METHOD OF THE SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE

#576
20240018130
2024-01-18

Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine

#577
20240018129
2024-01-18

COMPOUNDS AS PU. 1 INHIBITORS

#578
20240018128
2024-01-18

PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS

#579
20240018127
2024-01-18

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#580
20240018121
2024-01-18

NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE

#581
20240010636
2024-01-11

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE

#582
20240010635
2024-01-11

NOVEL INDIRUBIN DERIVATIVES HAVING HETEROBICYCLIC MOIETIES AND THE USE THEREOF

#583
20240002392
2024-01-04

Azetidinyl Pyrimidines and Uses Thereof

#584
20240002370
2024-01-04

PYRROLE-TYPE COMPOUNDS AND USES THEREOF FOR TREATING VIRAL INFECTIONS

#585
20240002368
2024-01-04

STING ANTAGONISTS AND USES THEREOF

#586
20240002366
2024-01-04

LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE

#587
20240002363
2024-01-04

HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

#588
20230416237
2023-12-28

AMIDE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#589
20230416235
2023-12-28

Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

#590
20230416233
2023-12-28

(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS

#591
20230416232
2023-12-28

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

#592
20230416231
2023-12-28

Uracil Derivatives for Stimulating Read-Through of Premature Termination Codons

#593
20230416226
2023-12-28

Azetidine Cyclic Ureas

#594
20230406842
2023-12-21

SMALL MOLECULE COMPOUND SERVING AS JAK KINASE INHIBITOR, AND USE THEREOF

#595
20230406841
2023-12-21

NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

#596
20230403931
2023-12-14

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

#597
20230391792
2023-12-07

METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION

#598
20230391786
2023-12-07

cGAS INHIBITORS

#599
20230391778
2023-12-07

INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES

#600
20230391752
2023-12-07

PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES